Genetic influences and causal pathways shared between cannabis use disorder and other substance use traits
Open Access
- 5 April 2024
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 29 (9) , 2905-2910
Abstract
Cannabis use disorder (CanUD) has increased with the legalization of the use of cannabis. Around 20% of individuals using cannabis develop CanUD, and the number of users has grown with increasing ease of access. CanUD and other substance use disorders (SUDs) are associated phenotypically and genetically. We leveraged new CanUD genomics data to undertake genetically-informed analyses with unprecedented power, to investigate the genetic architecture and causal relationships between CanUD and lifetime cannabis use with risk for developing SUDs and substance use traits. Analyses included calculating local and global genetic correlations, genomic structural equation modeling (genomicSEM), and Mendelian Randomization (MR). Results from the genetic correlation and genomicSEM analyses demonstrated that CanUD and cannabis use differ in their relationships with SUDs and substance use traits. We found significant causal effects of CanUD influencing all the analyzed traits: opioid use disorder (OUD) (Inverse variant weighted, IVW β = 0.925 ± 0.082), problematic alcohol use (PAU) (IVW β = 0.443 ± 0.030), drinks per week (DPW) (IVW β = 0.182 ± 0.025), Fagerström Test for Nicotine Dependence (FTND) (IVW β = 0.183 ± 0.052), cigarettes per day (IVW β = 0.150 ± 0.045), current versus former smokers (IVW β = 0.178 ± 0.052), and smoking initiation (IVW β = 0.405 ± 0.042). We also found evidence of bidirectionality showing that OUD, PAU, smoking initiation, smoking cessation, and DPW all increase risk of developing CanUD. For cannabis use, bidirectional relationships were inferred with PAU, smoking initiation, and DPW; cannabis use was also associated with a higher risk of developing OUD (IVW β = 0.785 ± 0.266). GenomicSEM confirmed that CanUD and cannabis use load onto different genetic factors. We conclude that CanUD and cannabis use can increase the risk of developing other SUDs. This has substantial public health implications; the move towards legalization of cannabis use may be expected to increase other kinds of problematic substance use. These harmful outcomes are in addition to the medical harms associated directly with CanUD.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (R01 AA026364)
- U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01 DA054869, R01 DA058862)
- U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
- U.S. Department of Veterans Affairs (I01CX001849-01)
- U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (R21 CA252916)
This publication has 42 references indexed in Scilit:
- Bias correction for inverse variance weighting Mendelian randomizationGenetic Epidemiology, 2023
- Two‐Sample Multivariable Mendelian Randomization Analysis Using RCurrent Protocols, 2021
- Risk of cardiovascular diseases in relation to substance use disordersDrug and Alcohol Dependence, 2021
- A large-scale genome-wide association study meta-analysis of cannabis use disorderThe Lancet Psychiatry, 2020
- What is the prevalence and risk of cannabis use disorders among people who use cannabis? a systematic review and meta-analysisAddictive Behaviors, 2020
- Incidence and predictors of drug overdoses among a cohort of >10,000 patients treated for substance use disorderDrug and Alcohol Dependence, 2020
- A systematic review of substance use and substance use disorders in patients with cancerGeneral Hospital Psychiatry, 2019
- Co-occurring substance use and mental disorders among adults with opioid use disorderDrug and Alcohol Dependence, 2019
- Is cannabis use associated with an increased risk of onset and persistence of alcohol use disorders? A three-year prospective study among adults in the United StatesDrug and Alcohol Dependence, 2016
- The role of cannabis use within a dimensional approach to cannabis use disordersDrug and Alcohol Dependence, 2009